Target Pipelines
Subscribe to
our newsletters!
It may be used once or twice a day depending on the dog’s symptoms and the severity of the symptoms. However, the fda also recognized that antibiotics do not only prevent infections, but Mostovskoy also treat existing infections. Tamoxifen is a kind of estrogen that has to be given for a long period, about 10-12 years in the majority of cases.
Clomid is used to help regulate hormone levels in your body. The highest concentration of Sellye come acquistare viagra con pagamento postepay cephalexin monohydrate 500 mg dosage for this concentration means the lowest volume is. I have also researched on http://www.hometool.com/index.htm.
Showing 21–40 of 62 results
- On the same day of purchaseThis product provides basic information on therapeutic antibodies in R&D targeting C-C chemokine receptor type 8 (CCR8).€ 300.00
- On the same day of purchaseThis product provides basic information on drug candidates in research and development targeting CD40 or CD40 ligand€ 300.00
- On the same day of purchaseThis product provides basic information on drug & imaging candidates in R&D targeting Fibroblast Activation Protein (FAP)€ 300.00
- On the same day of purchaseThis product provides basic information on approved drugs and drug candidates in R&D targeting folate receptor alpha (FRα)€ 300.00
- On the same day of purchaseThis product provides basic information on approved drugs and immunotherapy candidates in R&D targeting IGF-1 or its receptor (IGF-1R)€ 300.00
- On the same day of purchaseThis product provides basic information on approved drugs and drug candidates in R&D as biosimilar antibodies of Prolia & Xgeva (denosumab).€ 300.00
- July of 2023This report provides a competitor evaluation in the field of antibodies, proteins, peptides, RNA and small molecules acting as inibitors of complement C5 or antagonists of the C5a receptor€ 400.00
- On the same day of purchaseThis product provides basic information on approved drugs and drug candidates in R&D as biosimilar antibodies of Humira (adalimumab).€ 400.00
- On the same day of purchaseThis product provides basic information on approved drugs and drug candidates in R&D as biosimilar or biosuperior antibodies of Soliris (eculizumab).€ 300.00
- On the same day of purchaseThis product provides basic information on approved drugs and drug candidates in R&D as biosimilar or biosuperior antibodies of Xolair (omalizumab).€ 300.00
- On the same day of purchaseThis product provides basic information on approved drugs and drug candidates in R&D as biosimilar antibodies of Lucentis (ranibizumab)€ 300.00
- On the same day of purchaseThis product provides basic information on drug candidates in R&D as biosimilar antibodies of Eylea (aflibercept)€ 300.00
- On the same day of purchaseThis product provides basic information on approved drugs and drug candidates in R&D as biosimilar antibodies of Stelara (ustekinumab).€ 300.00
- On the same day of purchaseThis product provides basic information on approved drugs and drug candidates in R&D targeting thymic stromal lymphopoietin (TSLP) or its receptor (TSLP-R).€ 300.00
- February of 2023Antibody Target, Technology & Pipeline Database€ 1600.00
- July of 2022This report bundle includes four reports about novel cancer targets which have in common a compelling target expression profile with a low risk of on-target/off-tumor toxicity.€ 1800.00
- July of 2022The report evaluates opportunities for GPRC5D-targeted drug modalities within the competitive landscape.€ 600.00
- June of 2022The report evaluates opportunities for ROR1-targeted drug modalities within the competitive landscape€ 1050.00
- May of 2022This report describes and analyzes cadherin 17 (CDH17) as a target opportunity for development of effector-enhanced drug modalities€ 400.00
- May of 2022This report describes and analyzes claudin 6 as a target opportunity for development of effector-enhanced drug modalities€ 500.00